СРАВНИТЕЛЬНЫЙ АНАЛИЗ ФАКТОРОВ, АССОЦИИРОВАННЫХ С ТЯЖЕЛЫМ ТЕЧЕНИЕМ COVID-19 В ВОЗРАСТНЫХ ГРУППАХ ДО 60 ЛЕТ И СТАРШЕ 60 ЛЕТ
2023 жыл | Шығарылым: 1 | Беттер: 7-15
ON THE ROLE OF CLINICAL MENTORS IN THE CONTEMPORARY MEDICAL EDUCATION OF MEDICAL RESIDENTS
2023 жыл | Шығарылым: 1 | Беттер: 271-277
REVIEW OF ANTIMICROBIAL PROPERTIES OF HONEY CHEMICAL CONSTITUENTS - PART I
2023 жыл | Шығарылым: 1 | Беттер: 262-270
OBSTRUCTIVE SLEEP APNEA AND COGNITIVE FUNCTION WITH TYPE 2 DIABETES MELLITUS: A HOSPITAL-BASED CASE-CONTROL STUDY
2023 жыл | Шығарылым: 1 | Беттер: 94-99
ИСПОЛЬЗОВАНИЕ РАЗЛИЧНЫХ ИНСТРУМЕНТОВ ОЦЕНКИ КАЧЕСТВА ЖИЗНИ У ПАЦИЕНТОВ С КОЛОРЕКТАЛЬНЫМ РАКОМ: ОБЗОР ЛИТЕРАТУРЫ
2023 жыл | Шығарылым: 1 | Беттер: 253-261
ОРГАНИЗАЦИОННЫЕ АСПЕКТЫ УПРАВЛЕНИЯ РИСК-ОРИЕНТИРОВАННЫМИ ТЕХНОЛОГИЯМИ В ОРГАНИЗАЦИЯХ РОДОВСПОМОЖЕНИЯ
2025 жыл | Шығарылым: 1 | Беттер: 232-249
THE ROLE OF BIOCHEMICAL MARKERS IN BONE METABOLISM IN CHILDREN AND ADOLESCENTS. LITERATURE REVIEW
2025 жыл | Шығарылым: 1 | Беттер: 250-256
CLINICAL CASE: POSTSTREPTOCOCCAL ARTHRITIS ASSOCIATED WITH COVID-19
2025 жыл | Шығарылым: 1 | Беттер: 267-273
SYSTEMIC RETINOIDS IN THE MANAGEMENT OF MODERATE TO-SEVERE ACNE: A CLINICAL CASE STUDY
2025 жыл | Шығарылым: 1 | Беттер: 274-280
ANALYSIS OF THE RESPONSIBILITY STRUCTURE OF RESIDENTS “LSG FOR ELDERLY AND DISABLED COMMON TYPE ", G. FAMILIES
In the recent decade in Kazakhstan the proportion of persons older 60 was increased on 120 thousand. Older persons have a lot of problems and the first of which is health. Thus, the health assessment of the persons living in social establishments is an important aspect of social medicine. Structure analysis of morbidity and disability among the residents of KSU'S "Health care establishment for elderly and disabled persons of general type" of the Semey city will allow optimize basic directions of prophylaxis and care methods.
Толығырақ
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 131-132
THE FUNCTIONAL STATE OF CENTRAL NERVOUS SYSTEM LEAD PRODUCTION WORKERS
2012 жыл | Шығарылым: 2 | Беттер: 128-130
SOCIAL AND HYGIENIC ASPECTS OF THE HEALTH STATUS OF STUDENTS OF MEDICAL UNIVERSITY
2012 жыл | Шығарылым: 2 | Беттер: 126-128
THE TRACK RECORD OF THE EPYDEMIOLOGICAL FACTORS ON TUBERCULOSIS SEMIPALATINSKYI REGION FOR the LAST 37 YEARS (1975-2011 Y.Y.)
For an avoidance of the further diffusion of an infection contamination and body height of a case rate by tuberculosis among the population of Semipalatinsk region it is necessary to carry out (spend) the following measures:
- To strengthen in region propaganda about tuberculosis with wide use of mass media:
- By all subject to bunch of the population regularly to carry out (spend) against tuberculosis of engrafting.
- To strengthen work on early revealing of tuberculosis, is especial among children, teenagers, youth, bunches of the raised (increased) ... Толығырақ
- To strengthen in region propaganda about tuberculosis with wide use of mass media:
- By all subject to bunch of the population regularly to carry out (spend) against tuberculosis of engrafting.
- To strengthen work on early revealing of tuberculosis, is especial among children, teenagers, youth, bunches of the raised (increased) ... Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 121-122
UPSHOTS OF THE TREATMENT SICK MEDICINAL - A FIRM FORM OF THE TUBERCULOSIS
- Semipalatinsk region medicinal resistance by tuberculosis light more often are ill the men (60,9%) and mainly person from 1ү before 30 years (41,6%).
- Amongst sick with medicinal resistance by tuberculosis light fibrosis-cavernosis tuberculosis has formed 21,9%, but ca-seosis pneumonia 11,6%.
- Medicinal resistant MBT to combination four antituberculosis preparation is revealled beside 50,6% sick, but to combination isoniasidis with rifampicinum in 1,2% events.
Толығырақ
- Amongst sick with medicinal resistance by tuberculosis light fibrosis-cavernosis tuberculosis has formed 21,9%, but ca-seosis pneumonia 11,6%.
- Medicinal resistant MBT to combination four antituberculosis preparation is revealled beside 50,6% sick, but to combination isoniasidis with rifampicinum in 1,2% events.
Толығырақ
2012 жыл | Шығарылым: 2 | Беттер: 119-121